Treace Medical completes first surgery with new HyperPlate XM implant

Treace Medical Concepts, Inc. (Nasdaq: TMCI) announced the completion of the first surgical case using its HyperPlate XM Dynamic Compression Locking Implant, a new addition to the company's foot and ankle product portfolio.

The implant combines FastPitch locking screws with titanium compression plates, and is designed for midfoot and hindfoot procedures including talonavicular, calcaneocuboid, naviculocuneiform, and tarsometatarsal fusion applications, as well as Evans calcaneal osteotomies. The system includes single-use sterile instruments, among them the GreatReleaseXM Rapid Release Instrument for joint preparation.

Paul Dayton, DPM, of the Foot & Ankle Center of Iowa in Des Moines, performed the first case, which involved a talonavicular joint fusion. Dayton, a paid consultant of Treace, said the implant offered "a highly stable construct with an anatomic shape designed to promote fusion in these larger midfoot and hindfoot applications." He noted the GreatReleaseXM instrument made soft-tissue release "significantly more efficient."

John T. Treace, CEO and Chairman, said the launch "marks another important step in the continued expansion of our market-leading bunion and midfoot portfolio," and that the product is intended to expand the company's procedural reach across the foot and ankle.

Full commercial availability of the HyperPlate XM system is expected in the third quarter of 2026, according to a company press release.

You May Also Be Interested In

• Circle Internet Group (CRCL) PT Raised to $62 at Compass Point, 'we remain cautious'
• Citizens Starts Union Pacific (UNP) at Market Outperform
• Stride Inc. (LRN) call put ratio 1 call to 7.8 puts with a focus on July 80 puts